← Research library

Feasibility of Transport of 26 Biologically Active Ultrashort Peptides via LAT and PEPT Family Transporters

Research record · 2023

What was studied
Molecular transport feasibility investigation
Main finding
Examines transporter interactions for 26 ultrashort peptides. Feasibility at this level is not demonstrated oral bioavailability, brain delivery or clinical efficacy.

Study data at a glance

Participants or experimental model
Molecular transport feasibility investigation
Reported results
Examines transporter interactions for 26 ultrashort peptides. Feasibility at this level is not demonstrated oral bioavailability, brain delivery or clinical efficacy.
Study limitations and source details

Study limitations

  • Source-linked does not mean a completed risk-of-bias review.
  • A review is not an independent clinical replication; proposed mechanisms do not establish efficacy or safety.

Source details

Title, authors and abstract checked; detailed experimental/computational methods await appraisal.

Sources checked

Citation

Author affiliations · St. Petersburg Institute of Bioregulation and Gerontology · Pavlov Institute of Physiology, Russian Academy of Sciences

Study design unresolvedFull text available

V. Kh. Khavinson, N. S. Linkova, A. I. Rudskoy, M. G. Petukhov. Feasibility of Transport of 26 Biologically Active Ultrashort Peptides via LAT and PEPT Family Transporters Original article; author-hosted PDF

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards